Skip to main content
Premium Trial:

Request an Annual Quote

Cenix Prepares to Establish Belgian Subsidiary

Premium

Cenix BioScience this week announced that it will establish a new subsidiary to accelerate the firm's research and development capabilities in areas such as central nervous system-focused drug discovery and in vivo RNAi.

The subsidiary will be based in Belgium and reflects "a major growth and diversification initiative ongoing since 2008 to broaden the company's range of activities beyond [its core] cell-based RNAi services," Dresden, Germany-based Cenix said.

As reported by Gene Silencing News, the company disclosed in 2009 that it began expanding its operations to include contract-research work in animals and siRNA-delivery technology for both research and therapeutic applications (GSN 4/30/2009).

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.